GCT Development Centers | Academia’s Unique Contribution - World Medical Innovation Forum
WMIF Main Site

GCT Development Centers | Academia’s Unique Contribution

GCT Development Centers | Academia’s Unique Contribution

Tuesday, May 3, 2022

2:30 PM – 3:10 PM America Ballroom View Here

This panel will examine the role of academia in driving the promise of GCT. How does academic innovation contribute to the success of GCT? What are the risks and opportunities? Which models have proven most successful and what is the impact on clinical translation? How can these partnerships be accelerated?

Moderator:
Ravi Thadhani, MD
  • Chief Academic Officer, Mass General Brigham
Panelists:
Carl June, MD
  • Richard W. Vague Professor in Immunotherapy, Director, Center for Cellular Immunotherapies, Director, Parker Institute for Cancer Immunotherapy, University of Pennsylvania Perelman School of Medicine
Maria Millan, MD
  • President & CEO, California Institute for Regenerative Medicine
Richard Mulligan, PhD
  • Mallinckrodt Professor of Genetics, Emeritus, HMS
  • Executive Vice Chairman, Sana Biotechnology, Inc
Norman Sharpless, MD
  • Former Director, National Cancer Institute

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA